Clinical Trial

A Study to Detect the Radioactivity of 14C-SEP-380135 in Urine and Feces in Healthy Male Adults

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated March 6, 2026 (before its estimated April 10, 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of the present trial is to obtain information on the absorption, distribution, metabolism, excretion and pharmacokinetics (PK) of 14C-SEP-380135 and its metabolites following a single oral dose.
Trial Details
NCT Number NCT07455084
Lead Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
Conditions Schizophrenia
Enrollment 8 participants
Start Date 2026-03-20
Primary Completion 2026-04-10 (estimated)
Study Completion 2026-05-03 (estimated)
Updated on ClinicalTrials.gov 2026-03-06